If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

You may have COPD if you notice persistent, prolonged changes to your breathing. Symptoms can include: These symptoms usually worsen over time without treatment. You can also develop conditions ...

The growing prevalence of COPD among women can be attributed to a combination of biological, environmental, and societal ...

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Researchers have identified new lung function and blood test cutoffs to improve timely chronic hypercapnia management in ...

Oxygen is essential to life. The respiratory system works tirelessly to provide fresh oxygen to the body and ensure that all ...

Increasing air pollution and poor lifestyle choices are contributing to a rise in lung disorders, with Chronic Obstructive Pulmonary Disease (COPD) emerging as a significant concern. COPD ...

New Study Shows Promising Results for COPD Treatment Nov. 20 ... treat patients with opioids such as morphine to relieve symptoms, but there has been a lack of evidence as to whether this helps ...

Globally, COPD is also a leading cause of death. Data from the World Health Organization in 2021 ranked it as the fourth ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...